These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits. Rahmati K, Lernmark A, Becker C, Foltyn-Zadura A, Larsson K, Ivarsson SA, Törn C. Clin Lab; 2008; 54(7-8):227-35. PubMed ID: 18942490 [Abstract] [Full Text] [Related]
3. Actual condition survey regarding mismatch of measurements between radioimmunoassay and enzyme-linked immunosorbent assay tests for anti-glutamic acid decarboxylase antibody in real-world clinical practice. Oikawa Y, Kondo T, Shimada A, Seino Y, Kitaoka M. J Diabetes Investig; 2019 May; 10(3):685-689. PubMed ID: 30307126 [Abstract] [Full Text] [Related]
4. Comparison of measurements of autoantibodies to glutamic acid decarboxylase and islet antigen-2 in whole blood eluates from dried blood spots using the RSR-enzyme linked immunosorbent assay kits and in-house radioimmunoassays. Persson A, Becker C, Hansson I, Nilsson A, Törn C. Exp Diabetes Res; 2010 May; 2010():173652. PubMed ID: 20613950 [Abstract] [Full Text] [Related]
6. Clinical and genetic characteristics of people with type 1 diabetes who have discrepancies in titers of anti-glutamic acid decarboxylase antibody measured by radioimmunoassay and enzyme-linked immunosorbent assay. Takagi S, Miura J, Hoshina S, Uchigata Y, Babazono T. J Diabetes Investig; 2020 Mar; 11(2):356-362. PubMed ID: 31267698 [Abstract] [Full Text] [Related]
14. Association of Autoimmune Thyroid Disease with Anti-GAD Antibody ELISA Test Positivity and Risk for Insulin Deficiency in Slowly Progressive Type 1 Diabetes. Katahira M, Ogata H, Ito T, Miwata T, Goto M, Nakamura S, Takashima H. J Diabetes Res; 2018 Jul; 2018():1847430. PubMed ID: 30116734 [Abstract] [Full Text] [Related]
15. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus. Walikonis JE, Lennon VA. Mayo Clin Proc; 1998 Dec; 73(12):1161-6. PubMed ID: 9868413 [Abstract] [Full Text] [Related]
16. Development of glutamic acid decarboxylase 65 (GAD65) autoantibody assay using biotin-GAD65 fusion protein. Luo D, Rogers CN, Steed JT, Gilliam LK, Hampe CS, Lernmark A. J Biotechnol; 2004 Jul 01; 111(1):97-104. PubMed ID: 15196774 [Abstract] [Full Text] [Related]
17. Measurement of antibodies against glutamic acid decarboxylase 65 (GADA): two new 125I assays compared with [35S]GAD 65-ligand binding assay. Borg H, Fernlund P, Sundkvist G. Clin Chem; 1997 May 01; 43(5):779-85. PubMed ID: 9166231 [Abstract] [Full Text] [Related]
18. Expression of recombinant glutamic acid decarboxylase in insect larvae and its application in an immunoassay for the diagnosis of autoimmune diabetes mellitus. Trabucchi A, Bombicino SS, Targovnik AM, Marfía JI, Sabljic AV, Faccinetti NI, Guerra LL, Iacono RF, Miranda MV, Valdez SN. Sci Rep; 2019 Jan 29; 9(1):824. PubMed ID: 30696851 [Abstract] [Full Text] [Related]
19. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes. Westerlund A, Ankelo M, Ilonen J, Knip M, Simell O, Hinkkanen AE. J Autoimmun; 2005 Mar 29; 24(2):153-67. PubMed ID: 15829408 [Abstract] [Full Text] [Related]
20. Evaluation of a novel radioimmunoassay using 125I-labelled human recombinant GAD65 for the determination of glutamic acid decarboxylase (GAD65) autoantibodies. Marcovina SM, Landin-Olsson M, Essen-Möller A, Palmer JP, Lernmark A. Int J Clin Lab Res; 2000 Mar 29; 30(1):21-6. PubMed ID: 10984128 [Abstract] [Full Text] [Related] Page: [Next] [New Search]